Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Fidia Spa ( (IT:FDA) ) just unveiled an announcement.
Fidia S.p.A. has announced that its Half-Year Financial Report as of June 30, 2025, includes a paragraph from Deloitte & Touche S.p.A. highlighting significant uncertainties regarding business continuity. This disclosure raises concerns about the company’s ongoing operations and could impact its market position and stakeholder confidence.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.50 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A. is a leader in the technology of numerical control and integrated systems for computing, scanning, and milling complex shapes. It is listed on the Euronext Milan market of Borsa Italiana.
Average Trading Volume: 458,070
Technical Sentiment Signal: Strong Sell
Current Market Cap: €1.69M
See more data about FDA stock on TipRanks’ Stock Analysis page.